transcatheter aortic valve replacement

FDA Approves TAVR for Low-risk Patients Creates a Paradigm Shift in Cardiology

FDA opened transcatheter aortic valve replacement (TAVR) to low-risk patients with the simultaneous approvals of Edwards Lifesciences' | Feature | Heart Valve Technology | Jeff Zagoudis and Dave Fornell, Diagnostic and Interventional Cardiology (DAIC)

Read More

About Us

GCG Global Healthcare are specialists in healthcare excellence. Driven by a desire to improve healthcare and clinical solutions for everyone – patients, medical professionals and facilities. We aim to foster a culture of excellence through collaboration with industry experts and thought leaders to deliver better outcomes.